Related Experiment Video
Updated: Jan 3, 2026

Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness
Published on: May 2, 2017
Delirium in the critically ill patient.
Nathan E Brummel1, Timothy D Girard2
1Division of Pulmonary, Critical Care, and Sleep Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Delirium, a brain dysfunction affecting ICU patients, is harmful but often missed. Using screening tools and non-benzodiazepine sedation, like the ABCDEF bundle, effectively reduces delirium incidence and severity.
Area of Science:
- Critical Care Medicine
- Neuroscience
- Geriatrics
Background:
- Delirium is an acute brain dysfunction impacting consciousness, affecting up to 50% of intensive care unit (ICU) admissions.
- Previously underestimated, delirium is now recognized as detrimental to both short-term and long-term patient outcomes.
- Despite its high prevalence in critically ill patients, delirium frequently remains undiagnosed.
Purpose of the Study:
- To highlight the importance of recognizing and managing delirium in the ICU.
- To discuss modifiable risk factors and effective management strategies for delirium.
- To evaluate current treatment approaches, including pharmacologic and non-pharmacologic interventions.
Main Methods:
- Utilizing validated delirium screening tools for reliable detection in the ICU setting.
- Identifying and addressing modifiable risk factors, such as benzodiazepine use.
- Implementing non-pharmacologic strategies to mitigate sensory impairment, sleep deprivation, and immobility.
- Evaluating the efficacy of sedation strategies, favoring non-benzodiazepine-based approaches.
- Assessing the evidence for pharmacologic treatments, including antipsychotics and the "ABCDEF bundle".
Main Results:
- Benzodiazepines are identified as a dose-dependent risk factor for delirium.
- Non-benzodiazepine sedation strategies and non-pharmacologic interventions are effective in reducing delirium.
- Antipsychotics, while commonly used, lack support from placebo-controlled trials for delirium treatment.
- The "ABCDEF bundle" has demonstrated efficacy in multiple trials for delirium reduction.
Conclusions:
- Early and accurate detection of delirium using screening tools is crucial in the ICU.
- Modifying risk factors, particularly reducing benzodiazepine exposure and optimizing sedation, is key.
- Non-pharmacologic interventions and evidence-based bundles like "ABCDEF" are recommended for delirium management.
- Further research should focus on optimizing patient care to prevent and treat delirium effectively.
More Related Videos
Related Concept Videos
Acute Respiratory Failure-IV
Acute Respiratory Failure-III
Psychosis: Goals of Pharmacotherapy
Drug Dosing: Geriatric Patients
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Pneumonia II: Pathophysiology

